Innate Immune Receptor NLRX1: Potential Modulator of Glioblastoma PathophysiologyDurgesh Meena, Sushmita Jha, Vikas Janu et al.|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 4
IMMU-46. CROSS-TALK OF INNATE IMMUNE CELLS IN GLIOBLASTOMA PATHOPHYSIOLOGY: UNDERSTANDING NLRP3 AND NLRP12Sushmita Rajkhowa, Sushmita Jha, Durgesh Meena|Neuro-Oncology|2024Cited by 0
IMMU-42. UNRAVELING THE ROLE OF NLRX1 IN GLIOBLASTOMA TUMOR MICROENVIRONMENTDurgesh Meena, Sushmita Jha, Sushmita Rajkhowa|Neuro-Oncology|2024Cited by 0